Radiopharmaceuticals Market

Radiopharmaceuticals Market: Global Industry Analysis
and Opportunity Assessment, 2016–2026
March 2017
Report Id : REP-GB-1992
Status : Feb -2017
Category : Healthcare, Pharmaceuticals & Medical Devices
©2015 Future Market Insights, All Rights Reserved
Future Market Insights
Future Market Insights (FMI) is a premier provider of syndicated research reports, custom
research reports, and consulting services. We deliver a complete packaged solution, which
combines current market intelligence, statistical anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive framework, and future market trends.
We provide research services at a global as well as regional level; key regions include GCC,
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy,
Technology, Healthcare, and Retail.
We have a global presence with delivery centers across India specializing in providing global
research reports and country research reports. FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning
from every corner of the world to distill it to one thing – the perfect solution for our client.
Research Capabilities
Social Media
Customized Research
Syndicated Research
Investment Research
Social Media Research
Sector Coverage
Automotive and Transportation
Electronics, Semiconductor, and ICT
Retail and Consumer Products
Industrial Automation and Equipment
Chemicals & Materials
Food and Beverages
Services and Utilities
Energy, Mining, Oil, and Gas
Subscription Information
For detailed subscription information please contact
Hari. T (Sr. Manager - Global Business Development)
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268
Email: [email protected]
©2015 Future Market Insights, All Rights Reserved
Research Methodology (1/2)
Systematic Research Approach
Market profiling
Formulating discussion guide
Developing list of respondents
In-depth secondary research is used to
ascertain overall market size, top
industry players, top products, industry
associations, etc.
PMR formulates a detailed discussion
guide to conduct expert and industry
PMR develops a list of industry players
(manufacturers), distributors, retailers
and industry experts
Data collection
PMR conducts interviews with industry
experts, industry players, distributors
and retailers
Data validation
Data is validated by triangulation
method, wherein secondary, primary
and PMR analysis contribute to the final
Data analysis
Data is scrutinized using MS-Excel to
obtain qualitative and quantitative
insights about the industry
PMR delivers industry insights and
information in the required format
Research &
Data Filter
& Analysis
Identifying key opinion leaders
Questionnaire design
In-depth interviews
Coverage across value chain
Market participants
Key strengths
Product portfolio
Mapping as per value chain
Key focus segments
Primary Research #
Key industry experts
Channel study
Market dynamics
Secondary Research #
Company websites
Company annual
White papers
Financial reports
Paid Publications#
# includes sources of databases
©2015 Future Market Insights, All Rights Reserved
Radiopharmaceuticals Market
Global Demand for Radiopharmaceuticals Surges with Rising Incidences of Cancer
 Presence of radiopharmaceuticals in cancer medications has increased as research institutes have
derived ways in which radioisotopes can impede the maturation of malignant tumour, cells and
 Increasing significance of radiotracers in therapeutic care of cancer and cardiovascular diseases has
also impacted the growth in demand for radiopharmaceuticals.
In a recent report published by Future Market Insights, the global radiopharmaceuticals revenues in 2016
reached an estimated US$ 4,800 million value, and are anticipated to close in on US$ 8,500 million by the
end of 2026. In terms of revenue, the global radiopharmaceuticals market is projected to soar steadily at
5.9% CAGR.
Future Market Insights predicts that shorter half-life of radiopharmaceuticals, and lack of specified
guidelines for their use in commercial-scale drug production will restrict the market from growing at
higher rate. In the years to come, ageing research reactors from all corners of the world will be closed,
which will significantly bring down global production of radiopharmaceuticals. With respect to sourcing
these radiopharmaceuticals, the report predicts that nuclear reactors have accounted for more than 60%
of global market revenues till date.
Request For Report Sample:
©2015 Future Market Insights, All Rights Reserved
Radiopharmaceuticals Market
Shutting down these reactors, however, has propelled the installation of cyclotrons, which are also a
feasible source for radioisotopes. Hence, sales of radiopharmaceuticals derived from cyclotrons will
continue to increase, amassing more than US$ 6,500 million by the end of 2026.
Surging Demand for Technetium-99 Radioisotope
Production of radiopharmaceuticals can be classified into several key radioisotopes, the prominent ones
include, fluorine-18, leutetium-177, gallium-68, gallium-67 and technetium-99. In 2016, sales of
radiopharmaceuticals constituting technetium-99 amassed revenues worth over US$ 2,200 million,
globally. By the end of 2026, fluorine-18 radioisotope will continue to account for 16% of global
radiopharmaceuticals revenues. On the other hand, global radiopharmaceutical revenues accounted by
leutetium-177, gallium-68 and gallium-67, respectively, will soar at more than 6% CAGR through 2026.
North America – Dominant Region for Sales of Radiopharmaceuticals
Access to advanced medical facilities, highly-trained professionals and lucrative healthcare expenditure
adds up to make North America the most dominant region in global radiopharmaceuticals market. North
America’s radiopharmaceuticals revenues will grow at more than 6% CAGR, accounting for nearly 50% of
global revenues by the end of 2026. Companies such as Positron Corporation, GE Healthcare,
Mallinckrodt plc, Lantheus Holdings, Inc., and Nordion, Inc., are observed to be leading players in global
radiopharmaceuticals market, and are all based across North America.
©2015 Future Market Insights, All Rights Reserved
Radiopharmaceuticals Market
Siemens Healthineers is slated to remain the most dominant company in the global radiopharmaceuticals
market, accounting for over 40% of global revenues. Due to participation of Siemens and companies such
as Advanced Accelerator Applications (France), Bayer AG (Germany), IBA Radiopharma Solutions
(Belgium) and Eckert & Zeigler (Germany), Western Europe’s radiopharmaceuticals market is also
expected to expand progressively and close in on US$ 1,600 million valuation by the end of 2026.
Radiopharmaceuticals – Scope for Application & End-use
 Favourable growth opportunities for radiopharmaceutical manufacturers from around the world are
sited in therapeutic applications such as oncology, cardiology, neuroendocrinology, and neurology,
among others.
 In 2017 and beyond, consumption of radiopharmaceuticals for oncological procedures will gain
traction, registering revenue growth at 6% CAGR.
 On the other hand, radiopharmaceuticals consumed by neurological studies & treatment procedures
will surge at the highest rate, surpassing US$ 700 million valuation by 2026-end.
 Another key insight offered in the report suggests that radiopharmaceuticals used by diagnostic
imaging centres will increase over the forecast period.
©2015 Future Market Insights, All Rights Reserved
Click here to
Order a free sample
Table of Content
1. Executive Summary
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
3. Global Radiopharmaceuticals Market Analysis Scenario
3.1. Market Size (US$ Mn) and Forecast
3.1.1. Market Size and Y-o-Y Growth
3.1.2. Absolute $ Opportunity
3.2. Market Overview
3.2.1. Value Chain
4. Market Dynamics
4.1. Macro-economic Factors
4.2. Drivers
4.2.1. Supply Side
4.2.2. Demand Side
©2015 Future Market Insights, All Rights Reserved
Table of Content
4.3. Restraints
4.4. Opportunity
4.5.Forecast Factors – Relevance and Impact
4.6.Reimbursement Landscape
4.7.Regulatory Environment
4.8.Procedure Volume, By Therapeutic Area, by Region
5. Global Radiopharmaceuticals Market Analysis and Forecasts, By Radioisotope
5.1. Introduction
5.2. Basis Point Share (BPS) Analysis By Radioisotope
5.3. Y-o-Y Growth Projections By Radioisotope
5.4. Market Value Forecast By Radioisotope , 2015–2026
©2015 Future Market Insights, All Rights Reserved
Table of Content
5.4.1. Technetium-99
5.4.2. Fluorine-18
5.4.3. Iodine-131
5.4.4. Leutetium-177
5.4.5. Yttrium-90
5.4.6. Gallium-68
5.4.7. Gallium-67
5.4.8. Rubidium-82
5.4.9. Iodine-123
5.4.10. Indium-111
5.4.11. Others
5.5. Prominent Trends
5.6. Market Attractiveness By Radioisotope
6. Global Radiopharmaceuticals Market Analysis and Forecasts, By Application
6.1. Introduction
6.2. Basis Point Share (BPS) Analysis By Application
©2015 Future Market Insights, All Rights Reserved
Table of Content
7. Global Radiopharmaceuticals Market Analysis and Forecasts, By Source
7.1. Introduction
7.2. Basis Point Share (BPS) Analysis By Source
7.3. Y-o-Y Growth Projections By Source
7.4. Market Value Forecast By Source , 2015–2026
7.4.1. Cyclotrons
7.4.2. Nuclear Reactors
7.5. Prominent Trends
7.6. Market Attractiveness By Source
Click here to
Order a free sample
©2015 Future Market Insights, All Rights Reserved
To know more about us, please visit our website:
For sales queries or new topics email us on:
[email protected]
For media queries, contact the press office at
[email protected]
For other queries contact:
Hari. T (Sr. Manager - Global Business Development)
Future Market Insights: 3rd Floor,
207 Regent Street, London W1B 3HH
T: +44 20 7692 8790 | D: +44 20 3287 4268
Email: [email protected]
Thank You
Future Market Insights Global & Consulting Private Limited (FMI)
©2015 Future Market Insights, All Rights Reserved